Conn Bay (600572.SH) released its 2023 annual report. The company's revenue was 6.733 billion yuan...
According to the Zhitong Finance App, Conn Bay (600572.SH) released its 2023 annual report. The company's revenue was 6.733 billion yuan, an increase of 12.20% over the previous year. Net profit attributable to shareholders of listed companies was 592 million yuan, a year-on-year increase of 65.19%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 554 million yuan, an increase of 14.60% over the previous year. Basic earnings per share were $0.23. In addition, it is proposed to distribute a cash dividend of 2.00 yuan (tax included) for every 10 shares to all shareholders.
In 2023, the company will adhere to the development strategy of traditional Chinese medicine health as its core business, continue to promote large brand and variety projects, focus on increasing the growth space for core products, and maintain steady growth in business performance. The company actively promoted scientific and technological innovation-driven projects and further increased R&D investment. In 2023, it invested 312 million yuan in R&D, of which 298 million yuan was invested as a cost, an increase of 102 million yuan over 196 million yuan in 2022, an increase of 52.31%.